Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$524M |
| 2 |
Peloton Interactive
PTON
|
$465M |
| 3 |
Amazon
AMZN
|
$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
$290M |
| 5 |
NetEase
NTES
|
$264M |
Top Sells
| 1 |
Zoom
ZM
|
$965M |
| 2 |
Pinduoduo
PDD
|
$805M |
| 3 |
AbbVie
ABBV
|
$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$251B
| $1.87B | 2.04% | 26,841,171 -1,280,060 | -5% | -$89.4M |
|
2
Baidu
BIDU
$32.8B
| $1.86B | 2.02% | 8,589,864 -1,955,294 | -19% | -$423M |
|
|
3
Pinduoduo
PDD
$171B
| $1.27B | 1.38% | 7,146,243 -4,529,530 | -39% | -$805M |
|
4
VeriSign
VRSN
$25.5B
| $1.24B | 1.34% | 5,721,534 -851,656 | -13% | -$184M |
|
|
5
Bristol-Myers Squibb
BMY
$96B
| $1.15B | 1.24% | 18,480,630 -12,095,797 | -40% | -$750M |
|
6
Palo Alto Networks
PANW
$127B
| $1.08B | 1.18% | 3,052,729 -875,875 | -22% | -$311M |
|
7
Atlassian
TEAM
$46.6B
| $1.02B | 1.1% | 4,345,020 -1,552,794 | -26% | -$363M |
|
8
Monster Beverage
MNST
$60.9B
| $946M | 1.03% | 10,229,660 -2,254,630 | -18% | -$209M |
|
9
Target
TGT
$43.6B
| $944M | 1.02% | 5,345,665 -1,483,532 | -22% | -$262M |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $845M | 0.92% | 3,575,930 -1,631,002 | -31% | -$385M |
|
|
11
Chipotle Mexican Grill
CMG
$56.5B
| $823M | 0.89% | 593,242 -545,800 | -48% | -$757M |
|
|
12
Zoom
ZM
$24.4B
| $806M | 0.87% | 2,388,534 -2,859,325 | -54% | -$965M |
|
13
Kroger
KR
$44.9B
| $783M | 0.85% | 24,647,215 -4,480,873 | -15% | -$142M |
|
14
Biogen
BIIB
$19.4B
| $744M | 0.81% | 3,037,762 -779,199 | -20% | -$191M |
|
15
Franco-Nevada
FNV
$36.3B
| $695M | 0.75% | 5,542,590 +188,407 | +4% | +$23.6M |
|
16
Etsy
ETSY
$5.25B
| $681M | 0.74% | 3,830,108 +142,247 | +4% | +$25.3M |
|
17
Molina Healthcare
MOH
$9.8B
| $659M | 0.72% | 3,100,365 -254,794 | -8% | -$54.2M |
|
|
18
AbbVie
ABBV
$372B
| $650M | 0.71% | 6,062,575 -7,408,228 | -55% | -$794M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $646M | 0.7% | 1,993,800 -263,323 | -12% | -$85.4M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $643M | 0.7% | 4,113,704 -643,539 | -14% | -$101M |
|
21
Vodafone
VOD
$28.8B
| $609M | 0.66% | 36,982,976 -2,509,224 | -6% | -$41.4M |
|
22
United Therapeutics
UTHR
$13.8B
| $548M | 0.59% | 3,607,291 -101,727 | -3% | -$15.4M |
|
23
F5
FFIV
$18B
| $531M | 0.58% | 3,018,836 -154,138 | -5% | -$27.1M |
|
24
Fortinet
FTNT
$60.4B
| $526M | 0.57% | 3,540,484 -1,102,203 | -24% | -$164M |
|
25
GSK
GSK
$79.9B
| $525M | 0.57% | 14,271,421 -4,058,233 | -22% | -$149M |
|